1-3 of 3
Markus T. Rojewski
Close
Sort by
Journal Articles

RHAMM-R3 peptide vaccination in patients with acute myeloid leukemia, myelodysplastic syndrome, and multiple myeloma elicits immunologic and clinical responses

Michael Schmitt, Anita Schmitt, Markus T. Rojewski, Jinfei Chen, Krzysztof Giannopoulos, Fei Fei, Yingzhe Yu, Marlies Götz, Marta Heyduk, Gerd Ritter, Daniel E. Speiser, Sacha Gnjatic, Philippe Guillaume, Mark Ringhoffer, Richard F. Schlenk, Peter Liebisch, Donald Bunjes, Hiroshi Shiku, Hartmut Dohner, Jochen Greiner
Journal: Blood
Blood (2008) 111 (3): 1357–1365.
https://doi.org/10.1182/blood-2007-07-099366
Published: 2008
Journal Articles

Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications

Clinical Trials & Observations
Manfred Hönig, Michael H. Albert, Ansgar Schulz, Monika Sparber-Sauer, Catharina Schütz, Bernd Belohradsky, Tayfun Güngör, Markus T. Rojewski, Harald Bode, Ulrich Pannicke, Dominique Lippold, Klaus Schwarz, Klaus-Michael Debatin, Michael S. Hershfield, Wilhelm Friedrich
Journal: Blood
Blood (2006) 109 (8): 3595–3602.
https://doi.org/10.1182/blood-2006-07-034678
Published: 2006
Journal Articles

Highly Efficient mRNA- and cDNA-Based Transient Gene Delivery into Human Progenitor Cells.

Jochen Greiner, MD, Jan Torzewski, MD, Peter Ponsaerts, PhD, Markus T. Rojewski, PhD, Desiree Kronawitter, PhD, Hubert Schrezenmeier, MD, Vinzenz Hombach, MD, Hartmut Dohner, MD, Michael Schmitt, PhD, Markus Wiesneth, MD, Oliver Zimmermann, MD, Juliane M. Wiehe, PhD
Journal: Blood
Blood (2006) 108 (11): 5471.
https://doi.org/10.1182/blood.V108.11.5471.5471
Published: 2006